Showing results (251-260 of 290) with videos related to
Sort By:
Pageof 29
Science Translational Medicine|April 15, 2016
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependenceJustin M Balko, Luis J Schwarz, Na Luo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2016
Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular TestingAlexa B Schrock, Garrett M Frampton, Dana Herndon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2018
Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung CancerJessica J Lin, Viola W Zhu, Satoshi Yoda, et al.Cancer Discovery|April 23, 2016
EGFR Fusions as Novel Therapeutic Targets in Lung CancerKartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, et al.The Lancet. Oncology|October 30, 2020
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocolMary W Redman, Vassiliki A Papadimitrakopoulou, Katherine Minichiello, et al.European Urology|August 5, 2015
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder CancerElizabeth R Plimack, Roland L Dunbrack, Timothy A Brennan, et al.Cancer Research|January 11, 2017
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor SpectraJuliann Chmielecki, Mark Bailey, Jie He, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2015
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint InhibitorsSherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.JAMA|April 10, 2019
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic DatabaseGaurav Singal, Peter G Miller, Vineeta Agarwala, et al.Translational Oncology|August 1, 2021
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitorsJonathan W Riess, Shaila Rahman, Waleed Kian, et al.Pageof 29